OTC Markets EXMKT - Delayed Quote USD

ContraFect Corporation (CFRXQ)

Compare

0.0001

0.0000

(0.00%)

At close: October 31 at 4:00 PM EDT

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2022

12/31/2021

12/31/2020

12/31/2019

Operating Expense

30,214.0000

56,889.0000

47,265.0000

34,239.0000

27,866.0000

Operating Income

-30,214.0000

-56,889.0000

-47,265.0000

-34,239.0000

-27,866.0000

Net Non Operating Interest Income Expense

327.0000

81.0000

109.0000

192.0000

359.0000

Other Income Expense

5,749.0000

-8,345.0000

26,874.0000

5,891.0000

14,713.0000

Pretax Income

-24,138.0000

-65,153.0000

-20,282.0000

-28,156.0000

-12,794.0000

Net Income Common Stockholders

-24,138.0000

-65,153.0000

-20,282.0000

-28,156.0000

-12,794.0000

Diluted NI Available to Com Stockholders

-24,138.0000

-65,153.0000

-20,282.0000

-28,156.0000

-12,794.0000

Basic EPS

-15.03

-124.97

-44.12

-98.95

-123.20

Diluted EPS

-15.03

-124.97

-44.12

-98.95

-123.20

Basic Average Shares

4,322.1500

521.3590

459.6990

284.5440

103.5430

Diluted Average Shares

4,322.1500

521.3590

459.6990

284.5440

103.5430

Total Operating Income as Reported

-30,214.0000

-64,608.0000

-47,265.0000

-34,239.0000

-27,866.0000

Total Expenses

30,214.0000

56,889.0000

47,265.0000

34,239.0000

27,866.0000

Net Income from Continuing & Discontinued Operation

-24,138.0000

-65,153.0000

-20,282.0000

-28,156.0000

-12,794.0000

Normalized Income

-34,796.0000

-61,621.0000

-47,156.0000

-36,212.0000

-27,507.0000

Interest Income

327.0000

81.0000

109.0000

192.0000

359.0000

Net Interest Income

327.0000

81.0000

109.0000

192.0000

359.0000

EBIT

-30,214.0000

-56,889.0000

-47,265.0000

-34,239.0000

-27,866.0000

EBITDA

-30,055.0000

-56,735.0000

-47,117.0000

-34,071.0000

-27,697.0000

Reconciled Depreciation

159.0000

154.0000

148.0000

168.0000

169.0000

Net Income from Continuing Operation Net Minority Interest

-24,138.0000

-65,153.0000

-20,282.0000

-28,156.0000

-12,794.0000

Total Unusual Items Excluding Goodwill

10,658.0000

-3,532.0000

26,874.0000

8,056.0000

14,713.0000

Total Unusual Items

10,658.0000

-3,532.0000

26,874.0000

8,056.0000

14,713.0000

Normalized EBITDA

-40,713.0000

-53,203.0000

-73,991.0000

-42,127.0000

-42,410.0000

12/31/2019 - 9/12/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

CVM CEL-SCI Corporation

0.8730

-1.89%

VERU Veru Inc.

0.7635

+1.09%

DARE Daré Bioscience, Inc.

4.1600

-1.65%

CYDY CytoDyn Inc.

0.1324

+1.85%

BIOR Biora Therapeutics, Inc.

3.3494

-2.35%

AXSM Axsome Therapeutics, Inc.

88.84

-0.21%

SRPT Sarepta Therapeutics, Inc.

123.29

-2.15%

GERN Geron Corporation

4.1100

0.00%

GNPX Genprex, Inc.

2.1500

-4.44%

GLYC GlycoMimetics, Inc.

0.3826

-5.97%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

ContraFect Corporation (CFRXQ)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers